Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients

BACKGROUND: Treatment with selective vitamin D receptor activators such as paricalcitol have been shown to exert an anti-inflammatory effect in patients on hemodialysis, in addition to their action on mineral metabolism and independently of parathyroid hormone (PTH) levels. The objective of this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Izquierdo, María Jesús, Cavia, Mónica, Muñiz, Pilar, de Francisco, Angel LM, Arias, Manuel, Santos, Javier, Abaigar, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520723/
https://www.ncbi.nlm.nih.gov/pubmed/23186077
http://dx.doi.org/10.1186/1471-2369-13-159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520723/
https://www.ncbi.nlm.nih.gov/pubmed/23186077
http://dx.doi.org/10.1186/1471-2369-13-159

Ejemplares similares